Finch Therapeutics

Finch Therapeutics Group, Inc. (Finch) is a clinical-stage microbiome company dedicated to developing novel microbial therapies to serve patients with serious unmet medical needs, starting with recurrent C. difficile. Finch’s lead therapy, an investigational capsule containing lyophilized microbiota, is designed to restore a healthy microbiome and prevent recurrent C. difficile.

200 Inner Belt Road
Suite 400
Somerville, Massachusetts 02143